HEART UK Offers Guidance On The Safe Use Of Lipid Lowering Therapy During COVID-19 Pandemic
Patients with atherosclerotic cardiovascular disease (ASCVD) and obesity are at increased risk of severe illness and mortality if infected with COVID-19.
In the absence of evidence from a high-quality clinical trial, a consensus statement by HEART UK, based on available evidence and experts’ opinion, provides a guide for managing hyperlipidaemia during the pandemic.
According to the charity's Medical, Scientific and Research (MSR) committee, there is no need to withhold lipid-lowering medications because of the COVID-19 pandemic. This is especially important for patients who are at high risk of cardiovascular disease, in whom stopping lipid-lowering therapy can increase the risk of an atherosclerotic vascular event; patients who are being treated for hyperlipidaemia are advised to continue with their advised diet and lifestyle measures and should not interrupt their pharmacologic treatment.
However, if the possible risks from drug-drug interaction or organ damage outweigh the benefits in patients confirmed with COVID-19, the treatment should be reviewed by the medical team and alterations should be considered. COVID-19 causes direct liver injury or as part of the wider systemic inflammatory response syndrome. Nonetheless, it is important to recognise hepatic injury in COVID-19 patients as the majority of lipid lowering therapies are metabolised in the liver.
Handrean Soran, Chair of the HEART UK Medical, Scientific and Research Committee, said "The fatality rate as a result of (SARS-CoV-2) which causes Coronavirus Disease 2019 (COVID-19) is unpredictable but is amplified by several factors including advancing age, atherosclerotic cardiovascular disease, diabetes mellitus, hypertension and obesity. A large proportion of patients with these conditions are treated with lipid lowering medication and questions regarding the safety of continuing such medication in patients infected with COVID-19 have arisen. Some have reported an association between low circulating cholesterol levels and adverse outcomes in COVID-19 patients and suggested lipid lowering therapy may result in unfavourable outcomes in patients with COVID-19. However, a recent retrospective study reported a benefit from statin use - 28-day all-cause mortality was 5.2% in statin (a drug used to lower cholesterol) users compared to 9.4% in non-statin users. These observations, whilst encouraging, and plausible mechanistically via the anti-inflammatory and immunodulatory actions of statins, require confirmation."
Jules Payne, HEART UK's CEO says, ‘HEART UK works with world class clinicians from across the UK and the science underpins everything we do. HEART UK’s Medical, Scientific and Research Committee produced this expert statement of care to support clinical practice. It translates into the best treatment for patients during this pandemic and beyond.’
HEART UK's recommendations can be found on Atherosclerosis.
Call us on 01628 327288 or email us on firstname.lastname@example.org
Office hours are 9am-5pm. For enquiries outside these times, please call 01628 327288 and we will always try to accommodate deadlines.
Please note this out of hours number is for journalists only who are looking for urgent comment for a story.
- FH is a global health problem- FH Awareness Day 24th September
- Dr Pete Green is the new Chair of HEART UK
- UK NATIONAL SCREENING COMMITTEE REJECTS CALLS FOR UNIVERSAL CHILDHOOD SCREENING FOR INHERITIED HIGH CHOLESTEROL
- Emergency heart attack and stroke centres are still here for you- Jules Payne interviews Dr Ricardo Petraco
- Emergency heart attack and stroke centres are still here for you- Guest blog by Dr Ricardo Petraco
- A new cholesterol busting drug hits the headlines
- HEART UK responds to Dept of Health announcement on new cholesterol drug
- Volunteer for HEART UK...
- Is there such a thing as Healthy Diwali?
- National Cholesterol Month
- Child screening for cholesterol to find FH
- We are recruiting a voluntary chair position to join our Board of Trustees
- HEART UK latest radio advert
- Gene associated with bad cholesterol linked to early-onset Alzheimer’s disease
- What the London Marathon means to me
- Get cooking with the kids over Easter…
- Eggs and Cardiovascular Disease – What’s the Story?
- Lynne Garton joins HEART UK fight against heart disease and high cholesterol
- Daily Mail exposes "crackpot conspiracy theories" of the statin deniers
- Why we do what we do
- Is it as simple as ABC?
- Medical Misinformation: Vet the Message!
- We are recruiting!
- High cholesterol: Six ‘super foods’ to lower cholesterol and reduce heart attack risk- HEART UK featured in The Express
- Eating fried food and the link to heart disease- BMJ study
- One serving of fried chicken a day linked to 13% higher risk of death, reports CNN
- The NHS Long Term Plan
- Heart attack - the BEST exercise to prevent deadly symptoms revealed. HEART UK in The Express
- Four foods to help lower your cholesterol, reduce heart disease risks- HEART UK in The Sun
- Specialised Services Commissioning Policies published
- Cholesterol warning - just a handful of this ‘superfood’ could prevent high cholesterol - HEART UK in the Daily Express
- Thousands of heart attacks and deaths could be prevented by patients taking higher doses of statins
- Photos from the FCS Day of Action
- FCS Day of Action 5th December 2018
- Photographs from the Parliamentary launch of HEART UK's State of the Nation report 24th Oct 2018
- State of the Nation report launch
- HEART UK Conference
- HEART UK says BBC coconut oil claim not to be trusted
- Set up a Patient Support Group Meeting in your local community
- Saving Scottish Hearts for Valentine’s Day
- Why it's your heart that matters this Valentine's Day